Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.36
13.12.20
-
13.12.21
-5.96%
10.01.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€3.06
13.12.20
-
13.12.21
1.50%
11.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
buy
NIO Inc. ADR

Start price
Target price
Perf. (%)
€34.20
13.12.20
-
13.12.21
6.14%
11.03.21

Could be worthwhile Investment >10% per year
buy
Hensoldt AG

Start price
Target price
Perf. (%)
€13.99
13.12.20
-
13.12.21
-11.94%
14.12.21

Leading role in innovation
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Washington Prime Group Inc.

Start price
Target price
Perf. (%)
€8.09
13.12.20
€11.70
13.12.21
-16.52%
21.12.20

Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
buy
Avnet Inc.

Start price
Target price
Perf. (%)
€26.20
13.12.20
-
13.12.21
31.30%
14.12.21

Risky Investment
buy
Alico Inc

Start price
Target price
Perf. (%)
€25.80
13.12.20
-
13.12.21
13.95%
14.12.21

Risky Investment
buy
Nanostr.technol.

Start price
Target price
Perf. (%)
€57.50
13.12.20
-
13.12.21
-41.91%
14.12.21

Risky Investment
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.79
13.12.20
-
13.12.21
-29.55%
14.12.21

Risky Investment
buy
Xcel Energy Inc.

Start price
Target price
Perf. (%)
€53.50
13.12.20
-
13.12.21
11.29%
14.12.21

Risky Investment
buy
Thor Industries Inc.

Start price
Target price
Perf. (%)
€78.04
13.12.20
€95.00
13.12.21
17.15%
14.12.21

Could be worthwhile Investment >10% per year
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€142.00
13.12.20
€170.00
13.12.21
9.00%
14.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Ebix Inc.

Start price
Target price
Perf. (%)
€30.20
13.12.20
€35.00
13.12.21
-12.98%
14.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
E.ON SE

Start price
Target price
Perf. (%)
€8.97
13.12.20
-
-0.76%
14.12.20

Could be worthwhile Investment >10% per year
SLM Solutions Group AG

Start price
Target price
Perf. (%)
€15.50
13.12.20
-
13.12.21
5.42%
14.12.21

overvalued
Revenue decline/stagnation expected
EBIT decline/stagnation expected
United Labels

Start price
Target price
Perf. (%)
€0.92
13.12.20
-
13.12.21
180.43%
14.12.21

Probably not worthwhile Investment
High risks for its business
Growths much slower than the competition
Below average Management
Ming Le Sports AG

Start price
Target price
Perf. (%)
€1.27
13.12.20
€1.00
13.12.21
77.95%
03.04.21

Top 10 in its market
Future proof or reliable business model
Good rating
High risks for its business
Voltabox

Start price
Target price
Perf. (%)
€3.80
13.12.20
-
13.12.21
-55.21%
14.12.21

Probably not worthwhile Investment
Bad rating
High risks for its business
Growths much slower than the competition
Curis Inc.

Start price
Target price
Perf. (%)
€6.35
13.12.20
-
13.12.21
37.01%
16.02.21

Below average Marketposition
Probably not worthwhile Investment
Significant cyclical dependencies
Little known brand
Lexicon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.66
13.12.20
-
13.12.21
143.95%
16.02.21

Probably not worthwhile Investment
Significant cyclical dependencies
buy
Up Fintech Holding Ltd.

Start price
Target price
Perf. (%)
€4.74
13.12.20
€28.00
23.10.24
-18.57%
06.01.22

buy
Cisco Systems Inc.

Start price
Target price
Perf. (%)
€36.70
12.12.20
-
12.12.21
6.27%
15.02.21

Fair valuation
High dividend yield expected
Higher risks for its business
Verrica Pharmaceuticals

Start price
Target price
Perf. (%)
€8.75
12.12.20
-
12.12.21
-2.29%
13.12.21

Probably not worthwhile Investment
Inseego Corp.

Start price
Target price
Perf. (%)
€12.26
12.12.20
-
12.12.21
-54.63%
13.12.21

Probably not worthwhile Investment
PhaseBio Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€3.60
12.12.20
-
12.12.21
-42.22%
13.12.21

Probably not worthwhile Investment